SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,852.90 -876.37
( -1.17%)

Global Indices

Nasdaq

51,986.54 -36.87
(-0.07%)

Dow Jones

7,712.39 31.95
(0.42%)

Hang Seng

63,869.15 -1,047.55
(-1.61%)

Nikkei 225

10,765.28 -116.62
(-1.07%)

Forex

USD-INR

94.77 -0.08
(-0.08%)

EUR-INR

106.47 0.12
(0.11%)

GBP-INR

126.26 0.54
(0.43%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

47.2

13420.69

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.59

Back

Hindustan Oil Exploration Company consolidated net profit declines 85.78% in the June 2026 quarter

Aug 13,2026

Net profit of Hindustan Oil Exploration Company declined 85.78% to Rs 6.24 crore in the quarter ended June 2026 as against Rs 43.87 crore during the previous quarter ended June 2025. Sales rose 45.17% to Rs 114.18 crore in the quarter ended June 2026 as against Rs 78.65 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	114.18	78.65	45
OPM %	4.83	40.90	-
PBDT	22.39	30.58	-27
PBT	6.55	12.22	-46
NP	6.24	43.87	-86

73,852.90 -876.37 ( -1.17%)

51,986.54 -36.87 (-0.07%)

7,712.39 31.95 (0.42%)

63,869.15 -1,047.55 (-1.61%)

10,765.28 -116.62 (-1.07%)

94.77 -0.08 (-0.08%)

106.47 0.12 (0.11%)

126.26 0.54 (0.43%)

0.60 0.00 (-0.12%)